Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II
The majority of bimekizumab‐treated patients shifted from severe to mild and moderate IHS4 stages, and nearly 25% achieved an IHS4 of 0 by Week 48. Bimekizumab led to clinically meaningful improvements across IHS4 outcome measures. These data highlight an opportunity to address the need for effective treatments against draining tunnels.
Thrasyvoulos Tzellos +15 more
wiley +1 more source
Modeling Health Effects of Alternative Treatment Options during Surgical Delay to Inform Prioritization of Surgical Care. [PDF]
van Alphen A +7 more
europepmc +1 more source
Adoption of Telemedicine in Low-Resource Settings Through the Lens of Frugal Innovation: Protocol for a Systematic Review. [PDF]
Adlung C +6 more
europepmc +1 more source
DNA methylation as proxy of genetic, prenatal and perinatal psychiatric risk factors
Isaevska E +8 more
europepmc +1 more source
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER). [PDF]
Dongelmans EJ +18 more
europepmc +1 more source
Updated S2k hidradenitis suppurativa (HS) guidelines provide expert consensus on diagnosis, assessment and comorbidities. Expanded substantially since the 2015 version, they reflect rapid growth in HS literature and aim to improve generalist‐level patient care through evidence‐informed, consensus‐based guidance.
G. B. E. Jemec +36 more
wiley +1 more source
Youth Perspectives on the Climate Crisis: Motivation and Action Pathways. [PDF]
Kramer AW +6 more
europepmc +1 more source
Pathogenesis of hidradenitis suppurativa: From susceptibility to chronicity
This review describes hidradenitis suppurativa as a heterogeneous disorder in which genetic susceptibility, epithelial dysfunction, environmental exposures, immune activation and microbial ecology converge differently across patients and disease stages.
Kelsey R. van Straalen +5 more
wiley +1 more source
Real-world experiences with obesity medication in the Netherlands: A mixed methods study among patients and professionals. [PDF]
de Kruif JTCMA +2 more
europepmc +1 more source
ABSTRACT Background Brain autopsy has the potential to advance understanding of neurobiological and genetic mechanisms underlying intellectual disabilities (IDs), which may help improve health care and even inform therapies. However, for unknown reasons, it is rarely performed.
Hadassa Kwetsie +6 more
wiley +1 more source

